GB202210518D0 - Stable composition of chloral hydrate - Google Patents

Stable composition of chloral hydrate

Info

Publication number
GB202210518D0
GB202210518D0 GBGB2210518.3A GB202210518A GB202210518D0 GB 202210518 D0 GB202210518 D0 GB 202210518D0 GB 202210518 A GB202210518 A GB 202210518A GB 202210518 D0 GB202210518 D0 GB 202210518D0
Authority
GB
United Kingdom
Prior art keywords
stable composition
chloral hydrate
chloral
hydrate
stable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2210518.3A
Other versions
GB2617419A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atnahs Pharma UK Ltd
Original Assignee
Atnahs Pharma UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atnahs Pharma UK Ltd filed Critical Atnahs Pharma UK Ltd
Priority to GB2210518.3A priority Critical patent/GB2617419A/en
Publication of GB202210518D0 publication Critical patent/GB202210518D0/en
Priority to PCT/EP2023/053066 priority patent/WO2023139294A1/en
Priority to GB2301765.0A priority patent/GB2614972B/en
Publication of GB2617419A publication Critical patent/GB2617419A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
GB2210518.3A 2022-07-18 2022-07-18 Stable composition of chloral hydrate Pending GB2617419A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB2210518.3A GB2617419A (en) 2022-07-18 2022-07-18 Stable composition of chloral hydrate
PCT/EP2023/053066 WO2023139294A1 (en) 2022-07-18 2023-02-08 Stable composition of chloral hydrate
GB2301765.0A GB2614972B (en) 2022-07-18 2023-02-08 Stable composition of chloral hydrate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2210518.3A GB2617419A (en) 2022-07-18 2022-07-18 Stable composition of chloral hydrate

Publications (2)

Publication Number Publication Date
GB202210518D0 true GB202210518D0 (en) 2022-08-31
GB2617419A GB2617419A (en) 2023-10-11

Family

ID=84540117

Family Applications (2)

Application Number Title Priority Date Filing Date
GB2210518.3A Pending GB2617419A (en) 2022-07-18 2022-07-18 Stable composition of chloral hydrate
GB2301765.0A Active GB2614972B (en) 2022-07-18 2023-02-08 Stable composition of chloral hydrate

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB2301765.0A Active GB2614972B (en) 2022-07-18 2023-02-08 Stable composition of chloral hydrate

Country Status (2)

Country Link
GB (2) GB2617419A (en)
WO (1) WO2023139294A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA728764B (en) * 1971-12-29 1973-08-29 Squibb & Sons Inc One piece gelatin capsules containing chloral hydrate
DE102004049015A1 (en) * 2004-10-05 2006-04-06 G. Pohl-Boskamp Gmbh & Co. Kg Use of acids to stabilize chloral hydrate, especially in pharmaceutical compositions for filling gelatin capsules
WO2019158043A1 (en) 2018-02-13 2019-08-22 特丰制药有限公司 Stable chloral hydrate solution, preparation method thereof, and use thereof
CN112656758A (en) 2020-12-03 2021-04-16 成都施贝康生物医药科技有限公司 Stable chloral hydrate syrup, preparation method, quality control method and application thereof

Also Published As

Publication number Publication date
GB2614972A (en) 2023-07-26
WO2023139294A1 (en) 2023-07-27
GB2614972B (en) 2024-02-07
GB2617419A (en) 2023-10-11

Similar Documents

Publication Publication Date Title
IL305751A (en) Synthesis of omecamtiv mecarbil
EP3976070A4 (en) Shaped organoid compositions and methods of making same
EP3867328A4 (en) Azeotrope or azeotrope-like compositions of trifluoroiodomethane (cf3i) and hexafluoroacetone (hfa)
EP4090332A4 (en) Compositions of substituted pyrazolopyrimidines and uses thereof
GB2614972B (en) Stable composition of chloral hydrate
EP4003423A4 (en) Compositions and methods of using c/ebp alpha sarna
IL290324A (en) Compositions of trofinetide
IL304159A (en) Composition of bl-8040
EP4081233A4 (en) Composition and methods of manufacture
EP4135687A4 (en) Polycannabinoids, compounds, compositions and methods of use
EP4087559A4 (en) Topical compositions containing rofecoxib and methods of making and using the same
GB202012765D0 (en) Compositions and methods of production thereof
GB202311665D0 (en) Modification of composition
EP3980001A4 (en) Sustained-release compositions of alpha-ketoglutarate
GB202218197D0 (en) Methods of manufacturing compositions
GB202215264D0 (en) Use of urolithins
GB202314050D0 (en) Novel form of bemcentinib
IL306029A (en) Compositions having improved bioavailability of therapeutics
GB202218335D0 (en) Rs-32 low gwp compositions
FI4182303T3 (en) Thermodynamically stable form of sco-101
GB2607963B (en) Manufacture of pipelines
GB202311653D0 (en) Skiving for manufacture of components
IL311379A (en) Compositions and uses of oligo-chromopeptides and methods of making
GB202311874D0 (en) Manufacture of footwear
GB202313643D0 (en) Serping1-sarna compositions and methods of use